Litcius/Paper detail

FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT

Caner Civan, Duygu Has Şimşek, Emine Göknur Işık, Yasemin Şanlı, Serkan Kuyumcu

2023Clinical Nuclear Medicine11 citationsDOI

Abstract

ABSTRACT: A 69-year-old woman with breast cancer underwent 18 F-FDG PET/CT because of the increased CA-15-3 level. 18 F-FDG PET/CT showed multiple hypermetabolic lymph nodes (LNs) in the neck and mediastinum. The patient was also referred for 68 Ga-fibroblast activation protein inhibitor (FAPI) 04 PET/CT for further evaluation. However, 18 F-FDG-avid LNs were FAPI-negative on 68 Ga-FAPI-04 PET/CT. Supraclavicular LN biopsy confirmed the metastasis of breast cancer. Recent reports have focused on the potential of FAPI PET imaging in breast cancer; however, this case highlights that false-negative 68 Ga-FAPI-04-PET/CT findings should also be considered while evaluating metastatic spread.

Topics & Concepts

MedicineBreast cancerNuclear medicineBiopsyPET-CTMediastinumLymphCancerMetastatic breast cancerPositron emission tomographyRadiologyMetastasisPathologyInternal medicinePeptidase Inhibition and AnalysisProtease and Inhibitor MechanismsS100 Proteins and Annexins
FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT | Litcius